Verified ComparisonLast updated: 5 April 2026
Follistatin-344 vs BPC-157
Follistatin-344 inhibits myostatin, promoting muscle growth. BPC-157 repairs tissue across multiple domains. These represent different recovery mechanisms.
Follistatin 344
Recovery
4.2/ 5
A−
BPC-157
Recovery
4.5/ 5
A
Editor's note
Follistatin-344 targets muscle growth; BPC-157 targets broad tissue repair.
| Criterion | Follistatin 344 | BPC-157 |
|---|---|---|
| Mechanism | Myostatin inhibitor (muscle growth) | Tissue repair, angiogenesis |
| Muscle growth focus | Direct myostatin antagonism | Indirect, recovery-focused |
| Tissue repair breadth | Limited | Broad (tendon, gut, muscle, ligament) |
| Research literature depth | Growing | Extensive |
| WADA status | Prohibited (S4) | Prohibited (S0) |
Frequently asked questions
Follistatin-344 directly targets muscle growth; BPC-157 supports recovery.
Want to read the full reviews?